To further specify the correlation of DYRK1B expression with prognosis in different subtypes of breast cancer, including ER-positive, PR-positive, HER2-positive, and TNBC, the relationship of DYRK1B expression and overall survival or disease-free survival was analyzed in breast cancer patients (Table 1). Here, PGR is linked to breast carcinoma.